Death by inflammation: drug makers chase the master controller
Sign Up to like & getrecommendations! Published in 2019 at "Nature Biotechnology"
DOI: 10.1038/s41587-019-0023-4
Abstract: Companies are now looking at RIPK1 inhibitors for diseases like neurodegeneration and even cancer. read more here.
Keywords: chase master; death inflammation; makers chase; inflammation drug ... See more keywords